Scientific capability / Mechanistic Barrier and PBPK Modeling

Find the delivery assumption your mechanism depends on.

A promising mechanism still needs the right exposure, in the right compartment, for long enough. BioTwin’s barrier and exposure models investigate which delivery constraint may determine whether a proposed route is worth pursuing.

Current work Computational exposure models

Connect the molecule to a place and a timescale

The toolkit includes bounded models for absorption, barrier passage and time-dependent compartment exposure. A program might ask whether access, retention or conversion controls the next decision. Each question needs the appropriate operation and inputs.

PK-Sim and MoBi already support mechanistic exposure modeling, data comparison and reusable model components. BioTwin’s bounded methods are aimed at exposure questions within a particular intervention investigation.

Choose the model around the exposure decision
QuestionFamiliar approachBioTwin focusPractical consequence
Modeling workflowPK-Sim supports PBPK model creation, comparison with observations and refinement.Investigate a defined absorption, barrier or compartment/time-course hypothesis with the available operation.Select a model that answers the immediate program question.
CompositionMoBi provides reusable spatial, molecular, reaction and transport building blocks.Consider how exposure constrains another BioTwin mechanism or candidate-design question.Carry compatible concentration and timing assumptions into the follow-up analysis.
EvidenceModel credibility depends on appropriate inputs and agreement with relevant observations.BioTwin exposure predictions likewise need molecule- and setting-specific calibration.Use the result to choose a measurement; do not mistake it for measured bioavailability.

The BioTwin scope here is an early computational exposure investigation. Qualification depends on the model, data and intended decision.

Make the output a decision about evidence

A sensitivity analysis can identify a permeability, clearance or distribution measurement that would change the conclusion. Computational exposure is a hypothesis until calibrated against relevant data. Measured bioavailability and clinical dose selection require additional evidence.

Follow exposure into its biological consequence

Liver-directed mechanisms, local effect and subcellular partitioning each ask what a concentration estimate means in a different setting. Joining them requires compatible compartments, timing and biological assumptions.

Further reading

Which exposure measurement would change your route?

Describe the intended compartment, mechanism and unresolved delivery assumption. We can scope the model around that decision.